Table I.
Characteristic | Platinum-sensitive group | Platinum-resistant group | P-value |
---|---|---|---|
No. of patients | 35 | 29 | |
Median age, years (range) | 63 (36–81) | 62 (39–76) | 0.656a |
FIGO stage, n | 0.368b | ||
IIIA | 2 | 0 | |
IIIB | 3 | 1 | |
IIIC | 27 | 21 | |
IVA | 2 | 4 | |
IVB | 1 | 3 | |
Median CA125, U/ml (range) | 929 (25–30,075) | 1,422 (209–9,478) | 0.246a |
Postoperative residual tumor, n | <0.01b | ||
None | 9 | 3 | |
≤1 cm | 13 | 3 | |
>1 cm | 13 | 23 |
Mann-Whitney U test;
Fisher's exact test. FIGO, Federation of Gynecology and Obstetrics.